Skip to main content
. 2015 Aug 18;16(1):615. doi: 10.1186/s12864-015-1726-7

Fig. 7.

Fig. 7

Group 1 example: compound sulindac. Two genes from Group 1. Top panels: gene Eppk1-ps1 with the same direction of dose-response relationships, but different magnitude of fold change. Bottom panels: gene Gpx2 with different direction of dose-response relationships across platforms. Left panels: in vitro. Right panels: in vivo